51263 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 14
19:23 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Outperform | C$100.00→ C$105.00+5.0% |
|
Aug 14
19:23 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Outperform | C$100.00→ C$107.00+7.0% |
|
Aug 14
19:23 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Outperform | C$104.00→ C$106.00+1.9% |
|
Aug 14
19:23 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Outperform | C$102.00→ C$104.00+2.0% |
|
Aug 14
19:23 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | Buy | C$110.00→ C$115.00+4.5% |
|
Aug 14
19:23 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | C$104.00→ C$113.00+8.7% | |
|
Aug 14
19:23 UTC
|
CCL.B
CCL Industries
|
◎ Target | firm only | C$103.00→ C$110.00+6.8% | |
|
Aug 14
19:23 UTC
|
CATX
Perspective Therapeutics
|
◎ Target | Alec Stranahan ★★☆☆☆ #2362 | Neutral | $6.00→ $5.00-16.7% |
|
Aug 14
19:23 UTC
|
CAS
Cascades
|
◎ Target | firm only | Sec→ r Outperform | C$16.00→ C$20.50+28.1% |
|
Aug 14
19:23 UTC
|
CARG
CarGurus
|
◎ Target | Ronald Josey ★★★☆☆ #1547 | Neutral | $32.00→ $39.00+21.9% |
|
Aug 14
19:23 UTC
|
CAE
CAE
|
◎ Target | firm only | Buy | C$48.00→ C$49.00+2.1% |
|
Aug 14
19:23 UTC
|
CAE
CAE
|
◎ Target | firm only | Buy | C$43.00→ C$45.00+4.7% |
|
Aug 14
19:23 UTC
|
CADL
Candel Therapeutics
|
◎ Target | Alec Stranahan ★★☆☆☆ #2362 | Neutral | $9.00→ $12.00+33.3% |
|
Aug 14
19:23 UTC
|
BN
Brookfield
|
◎ Target | firm only | Buy | $60.00→ $61.00+1.7% |
|
Aug 14
19:23 UTC
|
BN
Brookfield
|
◎ Target | firm only | Sec→ r Outperform | $53.00→ $54.00+1.9% |
|
Aug 14
19:23 UTC
|
BLTE
Belite Bio
|
◎ Target | Judah Frommer ★★☆☆☆ #2401 | Overweight | $201.00→ $206.00+2.5% |
|
Aug 14
19:23 UTC
|
BDT
Bird Construction
|
◎ Target | firm only | Outperform | C$72.00→ C$92.00+27.8% |
|
Aug 14
19:23 UTC
|
BDT
Bird Construction
|
◎ Target | firm only | Outperform | C$57.00→ C$87.00+52.6% |
|
Aug 14
19:23 UTC
|
BDT
Bird Construction
|
◎ Target | firm only | Buy | C$85.00→ C$87.00+2.4% |
|
Aug 14
19:23 UTC
|
BDT
Bird Construction
|
◎ Target | firm only | C$71.00→ C$83.00+16.9% | |
|
Aug 14
19:23 UTC
|
BDT
Bird Construction
|
◎ Target | firm only | C$62.00→ C$83.00+33.9% | |
|
Aug 14
19:23 UTC
|
AYA
Aya Gold & Silver
|
◎ Target | firm only | C$35.00→ C$41.50+18.6% | |
|
Aug 14
19:23 UTC
|
AYA
Aya Gold & Silver
|
◎ Target | firm only | C$36.00→ C$41.00+13.9% | |
|
Aug 14
19:23 UTC
|
AVAH
Aveanna Healthcare
|
◎ Target | A.J. Rice ★★★★☆ #531 | Neutral | $8.00→ $13.00+62.5% |
|
Aug 14
19:23 UTC
|
AVAH
Aveanna Healthcare
|
◎ Target | John Ransom ★★★★☆ #806 | Strong-Buy | $13.00→ $15.00+15.4% |
|
Aug 14
19:23 UTC
|
AMAT
Applied Materials
|
◎ Target | Christian Schwab ★★★★☆ #526 | Buy | $530.00→ $585.00+10.4% |
|
Aug 14
19:23 UTC
|
AMAT
Applied Materials
|
◎ Target | Stacy Rasgon ★★★☆☆ #2138 | Outperform | $675.00→ $700.00+3.7% |
|
Aug 14
19:23 UTC
|
AMAT
Applied Materials
|
◎ Target | Shane Brett not yet tracked | Equal Weight | $646.00→ $642.00-0.6% |
|
Aug 14
19:23 UTC
|
AMAT
Applied Materials
|
◎ Target | Timothy Arcuri ★★★☆☆ #2158 | Buy | $705.00→ $675.00-4.3% |
|
Aug 14
19:23 UTC
|
AIT
Applied Industrial Technologies
|
◎ Target | Sabrina Abrams not yet tracked | Buy | $380.00→ $390.00+2.6% |
|
Aug 14
19:23 UTC
|
ACQ
AutoCanada
|
◎ Target | firm only | C$24.00→ C$27.00+12.5% | |
|
Aug 14
19:23 UTC
|
AC
Air Canada
|
◎ Target | firm only | C$26.00→ C$40.00+53.8% | |
|
Aug 14
19:23 UTC
|
AADX
Applied Aerospace & Defense
|
◎ Target | Ronald Epstein ★★☆☆☆ #2399 | Buy | $24.00→ $23.00-4.2% |
|
Aug 14
19:23 UTC
|
ALYA
Alithya Group
|
↓ Downgrade | firm only | Buy→ Hold | C$1.55→ C$1.15-25.8% |
|
Aug 14
19:23 UTC
|
ALYA
Alithya Group
|
↓ Downgrade | firm only | Outperform→ Sector Perform | C$1.60→ C$1.35-15.6% |
|
Aug 14
19:23 UTC
|
ALYA
Alithya Group
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Aug 14
19:23 UTC
|
PRV.UN
PRO Real Estate Investment Trust
|
↑ Upgrade | firm only | Neutral→ Outperformer | C$7.00→ C$7.50+7.1% |
|
Aug 14
19:23 UTC
|
PBL
Pollard Banknote
|
↑ Upgrade | firm only | Market Perform→ Outperform | C$21.50→ C$28.00+30.2% |
|
Aug 14
19:23 UTC
|
NPI
Northland Power
|
↑ Upgrade | firm only | Hold→ Buy | C$25.00 |
|
Aug 14
19:23 UTC
|
LCFS
Tidewater Renewables
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$12.50→ C$25.00+100.0% |
|
Aug 14
19:23 UTC
|
HLS
HLS Therapeutics
|
↑ Upgrade | firm only | Outperform→ Strong-Buy | C$7.00→ C$8.00+14.3% |
|
Aug 14
18:23 UTC
|
TT
Trane Technologies
|
◎ Target | Varun Govindaraj not yet tracked | Outperform | $555.00→ $575.00+3.6% |
|
Aug 14
18:23 UTC
|
S
SentinelOne
|
◎ Target | Ittai Kidron ★★★☆☆ #1483 | Outperform | $21.00→ $27.00+28.6% |
|
Aug 14
18:23 UTC
|
PTHS
Pelthos Therapeutics
|
◎ Target | Jeff Jones ★★★★☆ #630 | Outperform | $66.00→ $64.00-3.0% |
|
Aug 14
18:23 UTC
|
ONDS
Ondas
|
◎ Target | Timothy Horan ★★★☆☆ #1124 | Outperform | $16.00→ $18.00+12.5% |
|
Aug 14
18:23 UTC
|
NBIS
Nebius Group
|
◎ Target | Tyler Radke ★★★☆☆ #1227 | Buy | $278.00→ $324.00+16.5% |
|
Aug 14
18:23 UTC
|
KLAR
Klarna Group
|
◎ Target | James Faucette ★★★☆☆ #1879 | Equal Weight | $18.00→ $21.00+16.7% |
|
Aug 14
18:23 UTC
|
JCAP
Jernigan Capital
|
◎ Target | Danielle Brill ★★☆☆☆ #2287 | Buy | $26.00→ $30.00+15.4% |
|
Aug 14
18:23 UTC
|
JCAP
Jernigan Capital
|
◎ Target | Robert Dodd ★★★★★ #196 | Outperform | $21.00→ $24.00+14.3% |
|
Aug 14
18:23 UTC
|
GLOB
Globant
|
◎ Target | Arvind Ramnani ★★☆☆☆ #2815 | Hold | $44.00→ $38.00-13.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.